Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
21.14
-0.81 (-3.69%)
At close: Jul 25, 2025, 4:00 PM
21.20
+0.06 (0.28%)
After-hours: Jul 25, 2025, 4:20 PM EDT
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $1.25 billion as of July 25, 2025. Its market cap has increased by 15.27% in one year.
Market Cap
1.25B
Enterprise Value
961.71M
1-Year Change
15.27%
Ranking
Category
Stock Price
$21.14
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $1.25B, an increase of 28.03%. That is a compound annual growth rate of 10.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2025 | 1.29B | 17.78% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
| Feb 24, 2023 | 974.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.19B |
| Johnson & Johnson | 406.87B |
| AbbVie | 336.59B |
| Novo Nordisk | 309.02B |
| UnitedHealth Group | 265.35B |
| Novartis AG | 227.08B |
| AstraZeneca | 224.54B |
| Abbott Laboratories | 218.92B |